Femhrt and Pregnancy
Because the risks of femhrt are not fully understood, women should not use this medication during pregnancy. femhrt may increase the risk of birth defects or other problems. Also, there is no legitimate medical reason for pregnant women to use this medication. If you are using femhrt and pregnancy occurs, contact your healthcare provider for further instructions.
femhrt® (norethindrone acetate/ethinyl estradiol) is a prescription hormone replacement therapy medication that is used to treat menopause symptoms and to prevent osteoporosis in postmenopausal women. There is no accepted medical reason for pregnant women to use femhrt. Therefore, pregnant women should not take femhrt.
The U.S. Food and Drug Administration (FDA) uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category X is given to medications that should not be used during pregnancy, usually due to serious problems that could occur (such as birth defects or miscarriages).
Some studies have suggested that norethindrone (the progestin in femhrt) may increase the risk of birth defects, although other studies have shown no increased risk. Because the risks of femhrt are not fully understood (and because there is no accepted, legitimate medical reason for pregnant women to use femhrt), this medication should not be used during pregnancy.
femhrt should never intentionally be used during pregnancy. If you take femhrt and you think you may be pregnant, you should contact your healthcare provider for further instructions.